ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
98.355,16
0,15%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Augmedix Inc (AUGX)

  7. Augmedix Inc (AUGX) Notícias

AUGX

Augmedix (AUGX)

Augmedix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AUGX
DataHoraFonteTítuloCódigoCompanhia
13/11/202412:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AUGXAugmedix Inc
15/10/202410:32Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AUGXAugmedix Inc
04/10/202418:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
04/10/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AUGXAugmedix Inc
02/10/202410:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AUGXAugmedix Inc
02/10/202410:14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AUGXAugmedix Inc
02/10/202410:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUGXAugmedix Inc
02/10/202409:23GlobeNewswire Inc.Commure Completes Merger with AugmedixNASDAQ:AUGXAugmedix Inc
16/09/202418:14Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AUGXAugmedix Inc
29/08/202410:14Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AUGXAugmedix Inc
19/08/202418:18Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:AUGXAugmedix Inc
12/08/202417:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AUGXAugmedix Inc
12/08/202417:01GlobeNewswire Inc.Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024NASDAQ:AUGXAugmedix Inc
06/08/202408:00GlobeNewswire Inc.Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:AUGXAugmedix Inc
24/07/202410:07PR Newswire (US)Kuehn Law Encourages CHUY, AUGX, BCSA, and HUDA Investors to Contact Law FirmNASDAQ:AUGXAugmedix Inc
19/07/202408:00GlobeNewswire Inc.Augmedix to Join Forces with CommureNASDAQ:AUGXAugmedix Inc
20/06/202413:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AUGXAugmedix Inc
20/06/202408:00GlobeNewswire Inc.Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency DepartmentsNASDAQ:AUGXAugmedix Inc
04/06/202408:00GlobeNewswire Inc.Augmedix Reiterates Second Quarter and Full Year 2024 OutlookNASDAQ:AUGXAugmedix Inc
29/05/202408:00GlobeNewswire Inc.Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI OfficerNASDAQ:AUGXAugmedix Inc
13/05/202417:03GlobeNewswire Inc.Augmedix Delivers 40% Revenue Growth for First Quarter of 2024NASDAQ:AUGXAugmedix Inc
03/05/202408:00GlobeNewswire Inc.Augmedix to Participate in Upcoming Investor Conferences in May and June 2024NASDAQ:AUGXAugmedix Inc
30/04/202408:00GlobeNewswire Inc.Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:AUGXAugmedix Inc
25/04/202417:05GlobeNewswire Inc.Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 ListNASDAQ:AUGXAugmedix Inc
24/04/202408:00GlobeNewswire Inc.Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency DepartmentsNASDAQ:AUGXAugmedix Inc
09/04/202408:00GlobeNewswire Inc.Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual CareNASDAQ:AUGXAugmedix Inc
04/04/202408:00GlobeNewswire Inc.Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideNASDAQ:AUGXAugmedix Inc
19/03/202408:33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNASDAQ:AUGXAugmedix Inc
18/03/202417:01GlobeNewswire Inc.Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023NASDAQ:AUGXAugmedix Inc
12/03/202408:00GlobeNewswire Inc.Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix GoNASDAQ:AUGXAugmedix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AUGX

Seu Histórico Recente

BIT
P1QA69
BNP Paribas Issuance
LSE
BT44
B.a.t.if 32
BOV
ALPK3Q
Allpark Empreendimentos ... ON
BOV
QDFI11T
QR Bloomberg Defi Index ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados